Simply Wall St.
How New Price Targets Are Shaping The Story For Karyopharm Therapeutics (KPTI)
📊
AI Sentiment
Positive
7/10
Karyopharm Therapeutics Inc. News
Latest updates and market news for KPTI
2 news
Jan 20 - Jan 26, 2026
Page 1
MT Newswires
RBC Raises Price Target on Karyopharm Therapeutics to $23 From $19, Keeps Outperform Rating
📊
AI Sentiment
Positive
7/10
Share this news page